Loading stocks --
Market News
English اردو

BF Biosciences 1QFY27 Net Profit Rises 16% to Rs184.88m

BFBIO BF Biosciences Limited
Rs. 137.22 -0.74%
Stock ImpactPositive

BF Biosciences Limited (PSX: BFBIO) posted a 16% increase in its net profit for the first quarter ended September 30, 2026 (1QFY27), reaching Rs184.88m compared to Rs159.52m in the same period last year.

Basic and diluted earnings per share (EPS) grew 15% to Rs2.09, up from Rs1.81 in 3MFY26. The bottom-line growth was supported by a 14% rise in net revenue and stronger gross margins.

Description1QFY27 (Rs)1QFY26 (Rs)Change %
Net Revenue2,783,886,1162,432,294,309+14.5%
Gross Profit1,284,545,1331,038,330,250+23.7%
Net Profit184,882,110159,521,435+15.9%
Earnings Per Share (EPS)2.091.81+15.5%

Read the full story on the original publisher’s website.

Open original article